Endogenous and Recombinant Type I Interferons and Disease Activity in Multiple Sclerosis

Although treatment of multiple sclerosis (MS) with the type I interferon (IFN) IFN-β lowers disease activity, the role of endogenous type I IFN in MS remains controversial. We studied CD4+ T cells and CD4+ T cell subsets, monocytes and dendritic cells by flow cytometry and analysed the relationship...

Descripción completa

Detalles Bibliográficos
Autores principales: Sellebjerg, Finn, Krakauer, Martin, Limborg, Signe, Hesse, Dan, Lund, Henrik, Langkilde, Annika, Søndergaard, Helle Bach, Sørensen, Per Soelberg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368920/
https://www.ncbi.nlm.nih.gov/pubmed/22701554
http://dx.doi.org/10.1371/journal.pone.0035927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368920/
https://www.ncbi.nlm.nih.gov/pubmed/22701554
http://dx.doi.org/10.1371/journal.pone.0035927

Ejemplares similares